Loading
Life sciences · Journal article
Modern Rheumatology Case Reports · September 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Nontuberculous mycobacteria (NTM) are important pathogens in patients with chronic lung diseases, including rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Although acute exacerbations of ILD associated with NTM infection have been reported sporadically, cases involving pulmonary Mycobacterium abscessus infection remain extremely limited. We describe a fatal case of acute respiratory deterioration in a patient with RA-ILD following pulmonary infection with M. abscessus. A 76-year-old man with longstanding RA-ILD developed pulmonary NTM disease initially caused by Mycobacterium avium complex and subsequently complicated by M. abscessus infection. Intensive multidrug induction therapy led to transient clinical and radiographic improvement. However, two weeks after discharge, he was readmitted with rapidly progressive hypoxemic respiratory failure and newly developed bilateral diffuse ground-glass opacities on chest computed tomography. A comprehensive evaluation did not identify alternative infectious etiologies, and the overall findings were considered consistent with clinically suspected acute exacerbation of RA-ILD associated with pulmonary M. abscessus infection, although progressive pulmonary M. abscessus disease could not be completely excluded. Despite corticosteroid pulse therapy and broad antimicrobial coverage, the patient died six days after readmission. Subsequent analysis confirmed M. abscessus subsp. abscessus with resistance to macrolides and imipenem/cilastatin. This case highlights the diagnostic challenges in distinguishing acute exacerbation of RA-ILD from progressive pulmonary M. abscessus disease, raises the possibility that M. abscessus infection may be associated with acute respiratory deterioration in patients underlying RA-ILD, and underscores the importance of early recognition and optimal management of NTM infections in this high-risk population.